New York, NY: Independent testing of a random sampling of commercially marketed CBD-infused products finds that their potency is frequently mislabeled, according to a NBC 4 New York I-Team investigative report.
Investigators purchased CBD-infused products online and at local convenience stores and submitted the products to third-party independent testing. They reported, “Less than half the samples that were tested actually had the stated amount of THC inside the product.” Some products contained no CBD at all.
Other products tested positive for elevated levels of lead and pesticides.
While CBD products manufactured as part of state-specific cannabis access programs are subject to lab testing, commercially available products are entirely unregulated.
The NBC New York findings are consistent with those of prior reports — such as those here, here, here, here, here, here, and here — which similarly determined that many commercially available CBD-infused products are of variable potency and may contain adulterants. In February, a separate investigation conducted by KCTV Channel 5 (CBS) in St. Louis reported that none of the CBD-infused products they purchased over the counter at local retailers contained the amount of CBD listed on their labels.
For more information, contact Justin Strekal, NORML Political Director, at (202) 483-5500.